Page last updated: 2024-10-24

cefuroxime and Carcinoma, Non-Small Cell Lung

cefuroxime has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltayiannis, N1
Markogiannakis, A1
Sfyridis, P1
Manolis, EN1
Anagnostopoulos, D1
Bolanos, N1
Hatzimichalis, A1
Tsakris, A1

Other Studies

1 other study available for cefuroxime and Carcinoma, Non-Small Cell Lung

ArticleYear
The influence of local instillation of fusidic acid on the development of microbial complications after lung resection.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Bronchial Fistula; Carcin

2006